Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, six analysts have evaluated Twist Bioscience (NASDAQ:TWST), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $46.0, with a high estimate of $53.00 and a low estimate of $40.00. Recent analyst actions include several rating raises and one rating lower.
June 05, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Twist Bioscience has received mixed analyst ratings over the past three months, with a recent increase in the average 12-month price target to $46.0. Analysts have shown a trend of raising their ratings, indicating a positive outlook.
The increase in the average price target and the trend of rating raises suggest a positive short-term outlook for Twist Bioscience. Analysts' actions reflect a response to recent developments and improved market conditions for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100